{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T02:14:18Z","timestamp":1782267258499,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T00:00:00Z","timestamp":1732320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T00:00:00Z","timestamp":1732320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-A-251"],"award-info":[{"award-number":["2022-PUMCH-A-251"]}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2022YFC3601800"],"award-info":[{"award-number":["2022YFC3601800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Beijing Natural Science Foundation","award":["7242109"],"award-info":[{"award-number":["7242109"]}]},{"name":"National Key Clinical Specialty Project of China"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"DOI":"10.1186\/s12865-024-00669-1","type":"journal-article","created":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T03:48:13Z","timestamp":1732333693000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["IWR-1 attenuates the promotional effect of IL-36\u03b3 in a mouse model of psoriasis"],"prefix":"10.1186","volume":"25","author":[{"given":"Wen-Ming","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Meng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Feng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Zhong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,23]]},"reference":[{"key":"669_CR1","doi-asserted-by":"publisher","first-page":"109773","DOI":"10.1016\/j.cellsig.2020.109773","volume":"75","author":"Y Han","year":"2020","unstructured":"Han Y, Huard A, Mora J, da Silva P, Brune B, Weigert A. IL-36 family cytokines in protective versus destructive inflammation. Cell Signal. 2020;75:109773.","journal-title":"Cell Signal"},{"issue":"2","key":"669_CR2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/imm.13310","volume":"163","author":"VL Ngo","year":"2021","unstructured":"Ngo VL, Kuczma M, Maxim E, Denning TL. IL-36 cytokines and gut immunity. Immunology. 2021;163(2):145\u201354.","journal-title":"Immunology"},{"issue":"10","key":"669_CR3","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.7150\/ijms.20809","volume":"14","author":"W Wang","year":"2017","unstructured":"Wang W, Yu X, Wu C, Jin H. IL-36gamma inhibits differentiation and induces inflammation of keratinocyte via wnt signaling pathway in psoriasis. Int J Med Sci. 2017;14(10):1002\u20137.","journal-title":"Int J Med Sci"},{"issue":"1","key":"669_CR4","doi-asserted-by":"publisher","first-page":"20149","DOI":"10.1038\/s41598-020-76864-y","volume":"10","author":"S Watanabe","year":"2020","unstructured":"Watanabe S, Iwata Y, Fukushima H, Saito K, Tanaka Y, Hasegawa Y, Akiyama M, Sugiura K. Neutrophil extracellular traps are induced in a psoriasis model of interleukin-36 receptor antagonist-deficient mice. Sci Rep. 2020;10(1):20149.","journal-title":"Sci Rep"},{"issue":"12","key":"669_CR5","doi-asserted-by":"publisher","first-page":"6053","DOI":"10.4049\/jimmunol.1301481","volume":"192","author":"AM Foster","year":"2014","unstructured":"Foster AM, Baliwag J, Chen CS, Guzman AM, Stoll SW, Gudjonsson JE, Ward NL, Johnston A. IL-36 promotes myeloid cell infiltration, activation, and inflammatory activity in skin. J Immunol. 2014;192(12):6053\u201361.","journal-title":"J Immunol"},{"key":"669_CR6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.cytogfr.2020.06.006","volume":"55","author":"MF Neurath","year":"2020","unstructured":"Neurath MF. IL-36 in chronic inflammation and cancer. Cytokine Growth Factor Rev. 2020;55:70\u20139.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"669_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/bjd.19380","volume":"184","author":"L Nussbaum","year":"2021","unstructured":"Nussbaum L, Chen YL, Ogg GS. Role of regulatory T cells in psoriasis pathogenesis and treatment. Br J Dermatol. 2021;184(1):14\u201324.","journal-title":"Br J Dermatol"},{"key":"669_CR8","doi-asserted-by":"crossref","unstructured":"Iznardo H, Puig L. Exploring the role of IL-36 cytokines as a New Target in Psoriatic Disease. Int J Mol Sci 2021, 22(9).","DOI":"10.3390\/ijms22094344"},{"issue":"11","key":"669_CR9","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1172\/JCI63451","volume":"122","author":"L Tortola","year":"2012","unstructured":"Tortola L, Rosenwald E, Abel B, Blumberg H, Schafer M, Coyle AJ, Renauld JC, Werner S, Kisielow J, Kopf M. Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk. J Clin Invest. 2012;122(11):3965\u201376.","journal-title":"J Clin Invest"},{"key":"669_CR10","doi-asserted-by":"crossref","unstructured":"Mahil SK, Catapano M, Di Meglio P, Dand N, Ahlfors H, Carr IM, Smith CH, Trembath RC, Peakman M, Wright J et al. An analysis of IL-36 signature genes and individuals with IL1RL2 knockout mutations validates IL-36 as a psoriasis therapeutic target. Sci Transl Med. 2017;9(411).","DOI":"10.1126\/scitranslmed.aan2514"},{"issue":"6","key":"669_CR11","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1080\/09546634.2019.1689226","volume":"32","author":"J Chen","year":"2021","unstructured":"Chen J, Du J, Han Y, Wei Z. Correlation analysis between IL-35, IL-36gamma, CCL27 and psoriasis vulgaris. J Dermatolog Treat. 2021;32(6):621\u20134.","journal-title":"J Dermatolog Treat"},{"issue":"4","key":"669_CR12","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/jid.2014.532","volume":"135","author":"AM D\u2019Erme","year":"2015","unstructured":"D\u2019Erme AM, Wilsmann-Theis D, Wagenpfeil J, Holzel M, Ferring-Schmitt S, Sternberg S, Wittmann M, Peters B, Bosio A, Bieber T, et al. IL-36gamma (IL-1F9) is a biomarker for psoriasis skin lesions. J Invest Dermatol. 2015;135(4):1025\u201332.","journal-title":"J Invest Dermatol"},{"issue":"8","key":"669_CR13","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1111\/1346-8138.15370","volume":"47","author":"Y Xue","year":"2020","unstructured":"Xue Y, Liu Y, Bian X, Zhang Y, Li Y, Zhang Q, Yin M. Mir-205-5p inhibits psoriasis-associated proliferation and angiogenesis: Wnt\/beta-catenin and mitogen-activated protein kinase signaling pathway are involved. J Dermatol. 2020;47(8):882\u201392.","journal-title":"J Dermatol"},{"key":"669_CR14","doi-asserted-by":"crossref","unstructured":"Tokuyama M, Mabuchi T. New Treatment addressing the pathogenesis of Psoriasis. Int J Mol Sci. 2020;21(20).","DOI":"10.3390\/ijms21207488"},{"issue":"2","key":"669_CR15","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/JLB.5MR0120-439R","volume":"108","author":"X Ni","year":"2020","unstructured":"Ni X, Lai Y. Keratinocyte: a trigger or an executor of psoriasis? J Leukoc Biol. 2020;108(2):485\u201391.","journal-title":"J Leukoc Biol"},{"issue":"6","key":"669_CR16","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.jid.2019.12.008","volume":"140","author":"J Lee","year":"2020","unstructured":"Lee J, Song K, Hiebert P, Werner S, Kim TG, Kim YS. Tussilagonone ameliorates psoriatic features in keratinocytes and Imiquimod-Induced Psoriasis-Like lesions in mice via NRF2 activation. J Invest Dermatol. 2020;140(6):1223\u2013e12321224.","journal-title":"J Invest Dermatol"},{"issue":"17\u201318","key":"669_CR17","doi-asserted-by":"publisher","first-page":"6215","DOI":"10.1007\/s00018-021-03909-4","volume":"78","author":"J Byrne","year":"2021","unstructured":"Byrne J, Baker K, Houston A, Brint E. IL-36 cytokines in inflammatory and malignant diseases: not the new kid on the block anymore. Cell Mol Life Sci. 2021;78(17\u201318):6215\u201327.","journal-title":"Cell Mol Life Sci"},{"key":"669_CR18","doi-asserted-by":"crossref","unstructured":"Sugiura K, Fujita H, Komine M, Yamanaka K, Akiyama M. The role of interleukin-36 in health and disease states. J Eur Acad Dermatol Venereol 2024.","DOI":"10.1111\/jdv.19935"},{"key":"669_CR19","doi-asserted-by":"crossref","unstructured":"Ji YZ, Liu SR. Koebner phenomenon leading to the formation of new psoriatic lesions: evidences and mechanisms. Biosci Rep. 2019;39(12).","DOI":"10.1042\/BSR20193266"},{"issue":"1","key":"669_CR20","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1084\/jem.20050500","volume":"202","author":"FO Nestle","year":"2005","unstructured":"Nestle FO, Conrad C, Tun-Kyi A, Homey B, Gombert M, Boyman O, Burg G, Liu YJ, Gilliet M. Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J Exp Med. 2005;202(1):135\u201343.","journal-title":"J Exp Med"},{"issue":"4","key":"669_CR21","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.jid.2019.08.444","volume":"140","author":"M Catapano","year":"2020","unstructured":"Catapano M, Vergnano M, Romano M, Mahil SK, Choon SE, Burden AD, Young HS, Carr IM, Lachmann HJ, Lombardi G, et al. IL-36 promotes systemic IFN-I responses in severe forms of Psoriasis. J Invest Dermatol. 2020;140(4):816\u2013e826813.","journal-title":"J Invest Dermatol"},{"key":"669_CR22","doi-asserted-by":"crossref","unstructured":"German B, Wei R, Hener P, Martins C, Ye T, Gottwick C, Yang J, Seneschal J, Boniface K, Li M. Disrupting the IL-36 and IL-23\/IL-17 loop underlies the efficacy of calcipotriol and corticosteroid therapy for psoriasis. JCI Insight. 2019;4(2).","DOI":"10.1172\/jci.insight.123390"},{"issue":"4","key":"669_CR23","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.coph.2012.02.009","volume":"12","author":"JE Towne","year":"2012","unstructured":"Towne JE, Sims JE. IL-36 in psoriasis. Curr Opin Pharmacol. 2012;12(4):486\u201390.","journal-title":"Curr Opin Pharmacol"},{"key":"669_CR24","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3389\/fimmu.2018.00200","volume":"9","author":"C Bridgewood","year":"2018","unstructured":"Bridgewood C, Fearnley GW, Berekmeri A, Laws P, Macleod T, Ponnambalam S, Stacey M, Graham A, Wittmann M. IL-36gamma is a strong inducer of IL-23 in psoriatic cells and activates angiogenesis. Front Immunol. 2018;9:200.","journal-title":"Front Immunol"},{"issue":"2","key":"669_CR25","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1600-0846.2008.00336.x","volume":"15","author":"P Rosina","year":"2009","unstructured":"Rosina P, Giovannini A, Gisondi P, Girolomoni G. Microcirculatory modifications of psoriatic lesions during topical therapy. Skin Res Technol. 2009;15(2):135\u20138.","journal-title":"Skin Res Technol"},{"issue":"4","key":"669_CR26","first-page":"129","volume":"32","author":"A Ismaeel","year":"2023","unstructured":"Ismaeel A, Alhashimi F, Almossali Z, Alshaikh S, Selvam S, Janahi D. Immunohistochemical expression of vitamin D receptor and wnt signaling pathway molecules in psoriasis. Acta Dermatovenerol Alp Pannonica Adriat. 2023;32(4):129\u201333.","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"issue":"6","key":"669_CR27","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1111\/jocd.12966","volume":"18","author":"AGA Farag","year":"2019","unstructured":"Farag AGA, Shoaib MA, Samaka RM, Abdou AG, Mandour MM, Ibrahim RAL. Progranulin and beta-catenin in psoriasis: an immunohistochemical study. J Cosmet Dermatol. 2019;18(6):2019\u201326.","journal-title":"J Cosmet Dermatol"},{"issue":"7","key":"669_CR28","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1038\/jid.2010.67","volume":"130","author":"JE Gudjonsson","year":"2010","unstructured":"Gudjonsson JE, Johnston A, Stoll SW, Riblett MB, Xing X, Kochkodan JJ, Ding J, Nair RP, Aphale A, Voorhees JJ, et al. Evidence for altered wnt signaling in psoriatic skin. J Invest Dermatol. 2010;130(7):1849\u201359.","journal-title":"J Invest Dermatol"},{"issue":"6","key":"669_CR29","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1111\/j.1365-2133.2007.08195.x","volume":"157","author":"PJ Hampton","year":"2007","unstructured":"Hampton PJ, Ross OK, Reynolds NJ. Increased nuclear beta-catenin in suprabasal involved psoriatic epidermis. Br J Dermatol. 2007;157(6):1168\u201377.","journal-title":"Br J Dermatol"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-024-00669-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12865-024-00669-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-024-00669-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T16:02:27Z","timestamp":1732377747000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/s12865-024-00669-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,23]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["669"],"URL":"https:\/\/doi.org\/10.1186\/s12865-024-00669-1","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,23]]},"assertion":[{"value":"31 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocols were approved by Animal Ethics committee of Peking Union Medical College Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"78"}}